Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.08% shed 0.31% to $165.11 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.12% falling 0.20% to 3,783.28 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 0.14% to 30,273.87. Johnson & Johnson closed $21.58 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.76% fell 4.18% to $321.18, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.22% remained unchanged, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.33% fell 0.76% to $44.12. Trading volume (4.5 M) remained 2.7 million below its 50-day average volume of 7.2 M.